CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 50 enrolled
Drug / intervention
xylitol, 30g +3 moredietary
Likely dose
xylitol, 30gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04731363
NCT04731363N/AActive

Consumption of Oral Artificial Sweeteners on Platelet Aggregation and Polyol Excretion

The Cleveland Clinic·interventional·Posted Feb 1, 2021·Updated May 22, 2026

In Brief

A clinical study evaluating xylitol, 30g, erythritol, 30g, and 2 other interventions for Cardiovascular Risk Factor. Active but no longer recruiting, targeting 50 participants across 1 site.

Detailed Summary

The principal goal for the study is to examine whether ingestion of a beverage containing artificial sweeteners alters in vitro platelet aggregation. Because of the increasing number of cardiometabolic diseases, such as diabetes mellitus, in the population, the use of artificial sweeteners to replace free sugars has been gaining popularity. Two popular artificial sweeteners are erythritol and xylitol. Erythritol and xylitol are both naturally occurring polyols found in fruits and vegetables. They are potent artificial sweeteners with a higher sweetening intensity and lower calorie content than table sugar. Previous research has shown that the higher levels of sugar alcohols, like those used as artificial sweeteners, in the blood are related to a higher risk of cardiovascular complications, like heart attacks and strokes, and death. This may be because higher levels of sugar alcohols in one's blood may increase the activity of platelets, which would then increase the risk of heart attack and stroke. The investigators therefore want to find if consuming a single beverage that contains an artificial sweetener can raise the levels of sugar alcohols in the blood and if it can alter platelet function or aggregation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/AActive
2021202220232024202520262027
First PostedFeb 1, 2021
Enrollment StartMar 10, 2021
Primary CompletionAug 30, 2023
Study CompletionDec 1, 2026
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 5.4 years ago

Interventions

xylitol, 30gdietary

Intervention is a drink consisting of 300mL of water containing 30g of xylitol as a single oral dose.

erythritol, 30gdietary

Intervention is a drink consisting of 300mL of water containing 30g of erythritol as a single oral dose.

xylitol, 5gdietary

Intervention is a drink consisting of 300mL of water containing 5g of xylitol as a single oral dose.

glucose, 30gdietary

Intervention is a drink consisting of 300mL of water containing 30g of glucose (dextrose) as a single oral dose.